Latest MissionIR Articles

MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Bolsters Scientific Leadership Ahead of BiTAC(R) Clinical Development

September 10, 2026 12:08pm

VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting […]

Read Article

MissionIRNewsBreaks – AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGZ) Receives $7.3 Million in Follow-On Orders for Asian 5G O-RAN Deployment 

September 10, 2026 12:06pm

AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, […]

Read Article

MissionIRNewsBreaks – Silver Bow Mining Corp. (NYSE American: SBMT) Receives Bankruptcy Court Approval, Completes Initial Closing for Jefferson County Metallurgical Complex 

September 10, 2026 11:37am

Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after […]

Read Article

MissionIRNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Launches Joint AI Trading Research Group with European Institute of Management 

September 10, 2026 11:24am

Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance […]

Read Article

SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka

September 10, 2026 10:15am

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary […]

Read Article

Wrap Technologies Inc. (NASDAQ: WRAP) Broadens Public Safety Platform as Training, Technology and Response Capabilities Converge

September 10, 2026 9:30am

Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ: WRAP) is positioning itself at the intersection of these capabilities as it works to expand its public safety platform across a broader range of applications. Known […]

Read Article

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

September 10, 2026 9:00am

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) is advancing Lucid-MS toward a randomized, double-blind, placebo-controlled phase 2 trial in multiple sclerosis (“MS”) following U.S. Food and Drug Administration (“FDA”) clearance of its Investigational New Drug (“IND”) application. Lucid-MS is a patented, first-in-class, non-covalent […]

Read Article

MissionIRNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach

September 10, 2026 8:50am

SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across […]

Read Article

Greenland Mines Ltd. (NASDAQ: GRML) Completes Rare Earths Acquisition, Cementing Shift from Single Bet to Balanced Portfolio

September 09, 2026 9:30am

Junior mining stocks live and die by a single number: The price of whatever metal sits beneath their flagship projects. When that price falls, so does the company, regardless of how good the geology is. It is a structural weakness baked into most explorers’ business models, and it explains why single-asset miners trade at a […]

Read Article

MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate in IPAC-RS 2026 Nasal Innovation Forum

September 09, 2026 8:50am

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, taking place Sept. 16-17, 2026, in Jersey City, New Jersey. CEO Eric Weisblum said the forum provides an […]

Read Article

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial 

September 09, 2026 8:37am

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.  Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the company’s Lucid-MS drug candidate and its recent FDA clearance to begin a phase 2 clinical trial. The editorial, “A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach,” highlights Lucid-MS as a patented, […]

Read Article

MissionIRNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Highlights Nationwide Portfolio of Modular Housing Deployments

September 09, 2026 8:00am

BOXABL (NASDAQ: BXBL) an innovative technology company transforming the housing market with its modular building systems, highlighted a portfolio of completed and in-progress projects demonstrating deployments of its factory-built housing system nationwide. Projects include a permanent 12-unit park-model RV Casita installation at American Campground in Las Vegas, wildfire relief support in Pasadena, California, a 12-unit […]

Read Article

MissionIRNewsBreaks – Mobix Labs, Inc. (NASDAQ: MOBX) Secures Initial F-16 Component Production Order 

September 08, 2026 1:48pm

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial […]

Read Article

MissionIRNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus

September 08, 2026 8:30am

Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland […]

Read Article

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

September 08, 2026 8:20am

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) was featured in BioMedWire editorial coverage highlighting FDA clearance of the company Investigational New Drug (“IND”) application to begin a randomized, double-blind, placebo-controlled phase 2 trial of Lucid-MS in people with multiple sclerosis (“MS”). Lucid-MS, also […]

Read Article

MindWave Innovations Builds Toward a New Institutional Blockchain Ecosystem with MindChain and NILA

September 04, 2026 10:15am

Rather than pursuing a broad collection of digital-asset initiatives, MindWave Innovations Inc. (NYSE American: APUS) is concentrating its efforts around a defined blockchain ecosystem. The company’s current strategy centers on four interconnected components: MindChain, its native NILA token, MindWaveDAO and a Subnet architecture designed to support specialized blockchain environments. That structure puts MindChain at the foundation of the company’s […]

Read Article

SS Innovations International Inc. (NASDAQ: SSII) Is Turning India’s Surgical Robotics Opportunity Into a Global Growth Story

September 04, 2026 8:45am

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, presents an attractive proposition for investors in the medical-technology sector. The company’s SSi Mantra system is being deployed at an increasing number of hospitals, surgeons are performing thousands of procedures with the platform, and SSII is beginning to establish an installed base outside […]

Read Article

MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer

September 04, 2026 8:00am

VERAXA Biotech (NASDAQ: VRXA) a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph […]

Read Article